AdvanSix to Report Q4 Earnings: What's in the Cards for the Stock?

Core Viewpoint - AdvanSix Inc. (ASIX) is set to release its fourth-quarter 2024 results on February 21, with expectations of mixed performance due to various market factors and operational challenges [1][3]. Revenue Estimates - The Zacks Consensus Estimate for ASIX's sales in the upcoming quarter is $377.1 million, reflecting a decline of approximately 1.3% year-over-year [4]. - Nylon sales are estimated at$ 81 million, indicating a year-over-year increase of 3.5%, while Caprolactam sales are projected at $77 million, showing a decline of 6.7% [4]. - Ammonium Sulfate sales are expected to be$ 94 million, down 13.5% year-over-year, and Chemical Intermediates sales are estimated at $103 million, representing an 8.7% decline [5]. Factors Influencing ASIX Stock - AdvanSix benefits from a differentiated product portfolio and exposure to diverse end markets, with favorable demand and pricing expected to support performance [6]. - The nylon demand remains strong in engineered plastics and packaging applications, while the agricultural sector's fundamentals are positive for ammonium sulfate [8]. - The company experienced higher sales for nylon and ammonium sulfate in the third quarter, driven by strong demand for sulfur nutrition and favorable pricing [9]. Operational Challenges - The fourth-quarter performance may be negatively impacted by an extended turnaround, with an estimated$ 17 million unfavorable effect on pre-tax income due to maintenance and delayed ramp-up at the Hopewell site [10]. Earnings Prediction - The Earnings ESP for ASIX is -9.59%, and the Zacks Consensus Estimate for the fourth quarter indicates a loss of 37 cents, suggesting a lower likelihood of an earnings beat this season [12].